JP2001516728A5 - - Google Patents

Download PDF

Info

Publication number
JP2001516728A5
JP2001516728A5 JP2000511528A JP2000511528A JP2001516728A5 JP 2001516728 A5 JP2001516728 A5 JP 2001516728A5 JP 2000511528 A JP2000511528 A JP 2000511528A JP 2000511528 A JP2000511528 A JP 2000511528A JP 2001516728 A5 JP2001516728 A5 JP 2001516728A5
Authority
JP
Japan
Prior art keywords
composition
composition according
antibiotic
polymer
growth factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000511528A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001516728A (ja
Filing date
Publication date
Priority claimed from US08/944,022 external-priority patent/US5968542A/en
Application filed filed Critical
Publication of JP2001516728A publication Critical patent/JP2001516728A/ja
Publication of JP2001516728A5 publication Critical patent/JP2001516728A5/ja
Pending legal-status Critical Current

Links

JP2000511528A 1997-09-15 1998-09-08 デバイスとしての高粘性液状コントロールドデリバリーシステム Pending JP2001516728A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/944,022 US5968542A (en) 1995-06-07 1997-09-15 High viscosity liquid controlled delivery system as a device
US08/944,022 1997-09-15
PCT/US1998/018629 WO1999013913A2 (en) 1997-09-15 1998-09-08 High viscosity liquid controlled delivery system as a device

Publications (2)

Publication Number Publication Date
JP2001516728A JP2001516728A (ja) 2001-10-02
JP2001516728A5 true JP2001516728A5 (cg-RX-API-DMAC7.html) 2006-04-27

Family

ID=25480643

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000511528A Pending JP2001516728A (ja) 1997-09-15 1998-09-08 デバイスとしての高粘性液状コントロールドデリバリーシステム

Country Status (9)

Country Link
US (1) US5968542A (cg-RX-API-DMAC7.html)
EP (1) EP1015032A2 (cg-RX-API-DMAC7.html)
JP (1) JP2001516728A (cg-RX-API-DMAC7.html)
CN (1) CN1299290A (cg-RX-API-DMAC7.html)
AU (1) AU9475098A (cg-RX-API-DMAC7.html)
BR (1) BR9812313A (cg-RX-API-DMAC7.html)
CA (1) CA2303442A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ503366A (cg-RX-API-DMAC7.html)
WO (1) WO1999013913A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133507B2 (en) 2002-12-13 2012-03-13 Durect Corporation Oral drug delivery system

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
JP2002518351A (ja) 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
US6838050B1 (en) 1999-06-04 2005-01-04 Oxibio, Inc. Methods and devices for providing anti-infective activity to a medical device
US6465004B1 (en) * 1999-06-05 2002-10-15 Noven Pharmaceuticals, Inc. Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
US6627749B1 (en) * 1999-11-12 2003-09-30 University Of Iowa Research Foundation Powdered oxidized cellulose
US6566345B2 (en) 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
JP4361710B2 (ja) * 2000-04-19 2009-11-11 ジェネンテック・インコーポレーテッド 徐放製剤
US20020010150A1 (en) * 2000-04-28 2002-01-24 Cortese Stephanie M. Homostatic compositions of polyacids and polyalkylene oxides and methods for their use
US20040115236A1 (en) * 2000-10-06 2004-06-17 Chan Tai Wah Devices and methods for management of inflammation
WO2002062352A2 (en) * 2001-02-07 2002-08-15 Durect Corporation Devices and methods for management of bone density
WO2002076344A1 (en) * 2001-03-23 2002-10-03 Durect Corporation Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space
PT1397155E (pt) * 2001-06-21 2015-12-07 Genentech Inc Formulação de libertação sustentada
US6730772B2 (en) 2001-06-22 2004-05-04 Venkatram P. Shastri Degradable polymers from derivatized ring-opened epoxides
US6747121B2 (en) * 2001-09-05 2004-06-08 Synthes (Usa) Poly(L-lactide-co-glycolide) copolymers, methods for making and using same, and devices containing same
JP2003231622A (ja) * 2001-12-04 2003-08-19 Kao Corp 口腔用組成物
US7479535B2 (en) 2002-02-25 2009-01-20 Guilford Pharmaceuticals, Inc. Phosphorous-containing compounds with polymeric chains, and methods of making and using the same
FR2837099B1 (fr) * 2002-03-12 2005-03-18 Ethypharm Sa Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives
NZ535270A (en) * 2002-03-12 2006-11-30 Univ Montreal Composition having gelling properties for the sustained delivery of bioactive substances
KR100906547B1 (ko) 2002-03-12 2009-07-07 에띠빠흠 생활성 물질의 지속적 전달을 위한 겔화 특성을 갖는 조성물
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ITMI20021392A1 (it) * 2002-06-25 2003-12-29 Nicox Sa Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
US6949066B2 (en) * 2002-08-21 2005-09-27 World Heart Corporation Rotary blood pump diagnostics and cardiac output controller
JP2006502158A (ja) 2002-09-06 2006-01-19 デュレクト コーポレーション グルタメート媒介神経伝達のモジュレーターの内耳への送達
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US6800663B2 (en) * 2002-10-18 2004-10-05 Alkermes Controlled Therapeutics Inc. Ii, Crosslinked hydrogel copolymers
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
EP1644004A4 (en) 2003-06-20 2010-10-06 Ronald Aung-Din LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
CA2557670C (en) * 2004-03-01 2009-05-19 Bsn Medical Inc. Soft cast material
WO2005089670A1 (en) * 2004-03-15 2005-09-29 Durect Corporation Pharmaceutical compositions for administration to a sinus
US20050232876A1 (en) * 2004-04-19 2005-10-20 Robin Lynn Minga Skin care compositions
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
DK2767292T3 (en) 2004-09-17 2016-12-19 Durect Corp RENEWABLE local anesthetic COMPOSITION CONTAINING SAIB
ATE551995T1 (de) * 2004-10-21 2012-04-15 Durect Corp Transdermale abgabesysteme
DE102005002703C5 (de) * 2005-01-19 2013-07-04 Heraeus Kulzer Gmbh Antibiotische Beschichtung von Implantaten sowie Verfahren zur antibiotischen Beschichtung
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2007056142A2 (en) * 2005-11-02 2007-05-18 Theraquest Biosciences, Llc Methods of preventing the serotonin syndrome and compositions for use therefor
US9125833B2 (en) * 2005-11-02 2015-09-08 Relmada Therapeutics, Inc. Multimodal abuse resistant and extended release opioid formulations
US8329744B2 (en) * 2005-11-02 2012-12-11 Relmada Therapeutics, Inc. Methods of preventing the serotonin syndrome and compositions for use thereof
US20090082466A1 (en) * 2006-01-27 2009-03-26 Najib Babul Abuse Resistant and Extended Release Formulations and Method of Use Thereof
CA2637173C (en) * 2006-01-31 2015-12-01 Tyco Healthcare Group Lp Super soft foams
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7875697B2 (en) * 2006-06-29 2011-01-25 Medtronic, Inc. Poly(orthoester) polymers, and methods of making and using same
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
MX2009000053A (es) * 2006-07-12 2009-02-23 Controlled Therapeutics Sct Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina.
CA2671197A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophobic abuse deterrent delivery system
US8187636B2 (en) 2006-09-25 2012-05-29 Atlantic Pharmaceuticals, Inc. Dosage forms for tamper prone therapeutic agents
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
US20080140106A1 (en) * 2006-12-12 2008-06-12 Kimberly-Clark Worldwide, Inc. Enhanced cuff sealing for endotracheal tubes
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
US20080234727A1 (en) * 2007-03-22 2008-09-25 Venkat Garigapati Novel Carriers For Coating Growth Factors Onto Sutures
CN101677952B (zh) * 2007-05-18 2012-12-05 杜雷科特公司 改进的贮库制剂
EP2152315B1 (en) 2007-05-25 2016-01-06 Indivior UK Limited Sustained delivery formulations of risperidone compounds
JP5535066B2 (ja) * 2007-06-08 2014-07-02 トロイカ ファーマスーティカルズ リミテッド ジクロフェナクの新規な非水性外用溶液およびそれを調製するためのプロセス
US8252302B2 (en) * 2007-06-11 2012-08-28 Edge Therapeutics, Inc. Methods and compositions to treat hemorrhagic conditions of the brain
US10092524B2 (en) 2008-06-11 2018-10-09 Edge Therapeutics, Inc. Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
CN101801405A (zh) 2007-08-07 2010-08-11 先进科技及再生医学有限责任公司 包含于酸性水溶液中的gdf-5的蛋白质配方
EP2067471B1 (en) 2007-12-06 2018-02-14 Durect Corporation Oral pharmaceutical dosage forms
US20090181068A1 (en) * 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
WO2009100222A1 (en) 2008-02-08 2009-08-13 Qps Llc Non-polymeric compositions for controlled drug delivery
EP2254559B1 (en) 2008-02-08 2018-10-10 Foresee Pharmaceuticals Co., Ltd. Composition for sustained release delivery of proteins or peptides
JP5599778B2 (ja) * 2008-04-14 2014-10-01 デピュイ・シンセス・プロダクツ・エルエルシー 液体緩衝gdf−5製剤
US8475823B2 (en) 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
US8956642B2 (en) 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
US8524267B2 (en) 2008-04-18 2013-09-03 Warsaw Orthopedic, Inc. Dexamethasone formulations in a biodegradable material
WO2009152374A2 (en) 2008-06-12 2009-12-17 Medtronic Xomed, Inc. Method for treating chronic wounds
CA2729346A1 (en) 2008-06-30 2010-01-14 Afgin Pharma, Llc Topical regional neuro-affective therapy
WO2010025219A1 (en) * 2008-08-28 2010-03-04 Tyco Healthcare Group Lp Antimicrobial foam compositions, articles and methods
US12171463B2 (en) 2008-10-03 2024-12-24 Femasys Inc. Contrast agent generation and injection system for sonographic imaging
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US20120076734A1 (en) * 2010-09-15 2012-03-29 Jacob Olson Radiopaque antibiotic dental paste and uses thereof
CN105748402B (zh) * 2010-11-24 2022-06-03 杜雷科特公司 生物可降解的药物递送组合物
ES2646720T3 (es) 2011-02-11 2017-12-15 Edge Therapeutics, Inc. Composiciones y métodos para mejorar el pronóstico de un humano con hemorragia subaracnoidea
PL2626092T3 (pl) * 2011-04-01 2016-02-29 Zhuhai Ortus Biotechnology Co Ltd Medyczny wchłanialny hemostatyczny materiał do ran z obnażeniem kości i sposób jego wytwarzania
AU2012240131B2 (en) 2011-04-05 2017-07-20 Edge Therapeutics Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
AR082266A1 (es) 2011-05-13 2012-11-28 Univ Nac Del Litoral Microparticula inyectable de liberacion controlada
US9399019B2 (en) 2012-05-09 2016-07-26 Evonik Corporation Polymorph compositions, methods of making, and uses thereof
CN103830767A (zh) * 2012-11-26 2014-06-04 韩冰 乙酸异丁酸蔗糖酯凝胶及其用途
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
WO2014164754A1 (en) * 2013-03-11 2014-10-09 Durect Corporation Injectable controlled release composition comprising high viscosity liquid carrier
US9040093B2 (en) 2013-03-13 2015-05-26 Orthovita, Inc. Bone graft materials containing calcium phosphate and chitosan
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
HK1220445A1 (zh) 2013-03-15 2017-05-05 Durect Corporation 具有摇溶性以及增强的溶解再现性和稳定性的组合物
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
CA2936806C (en) * 2014-01-20 2022-03-15 Merial, Inc. Topical delivery formulation
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
US11065201B2 (en) 2014-11-21 2021-07-20 Technical University Of Denmark Gel formulations for local drug release
US10682340B2 (en) 2016-06-30 2020-06-16 Durect Corporation Depot formulations
CN109310680B (zh) 2016-06-30 2022-11-01 度瑞公司 长效配制物
CN109475505A (zh) 2016-07-06 2019-03-15 度瑞公司 具有药物组成物、屏障层及药物层的口服剂型
WO2018225050A1 (en) * 2017-06-09 2018-12-13 Association For The Advancement Of Tissue Engineering Cell Based Technologies & Therapies (A4Tec) - Associação Sucrose acetate isobutyrate-based compositions, methods and uses thereof
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods
WO2024014517A1 (ja) * 2022-07-15 2024-01-18 デクセリアルズ株式会社 細胞の培養方法、治療用組成物の製造方法及び治療用組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1088992A (en) * 1963-09-19 1967-10-25 Squibb & Sons Inc Protective dressings
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4530840A (en) * 1982-07-29 1985-07-23 The Stolle Research And Development Corporation Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
US4906474A (en) * 1983-03-22 1990-03-06 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
US4725442A (en) * 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4891225A (en) * 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
JPH0296516A (ja) * 1988-09-29 1990-04-09 Dainippon Pharmaceut Co Ltd 粒剤およびその製造方法
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324520A (en) * 1988-12-19 1994-06-28 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
US5149543A (en) * 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
JP3313124B2 (ja) * 1991-07-31 2002-08-12 森下仁丹株式会社 親水性物質を内容物とするシームレスカプセルおよびその製法
JPH07115901A (ja) * 1993-10-28 1995-05-09 Fuji Bibaretsuji:Kk ドコサヘキサエン酸高含有乳化組成物及び飲料
DE69431071T2 (de) * 1993-12-29 2003-03-20 Matrix Pharma Zusammensetzung für lokale freigabe von zytostatika
EP1525858A1 (en) * 1995-06-07 2005-04-27 Durect Corporation High viscosity liquid controlled delivery system
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133507B2 (en) 2002-12-13 2012-03-13 Durect Corporation Oral drug delivery system
US8147870B2 (en) 2002-12-13 2012-04-03 Durect Corporation Oral drug delivery system
US8153152B2 (en) 2002-12-13 2012-04-10 Durect Corporation Oral drug delivery system
US8168217B2 (en) 2002-12-13 2012-05-01 Durect Corporation Oral drug delivery system
US8354124B2 (en) 2002-12-13 2013-01-15 Durect Corporation Oral drug delivery system
US8420120B2 (en) 2002-12-13 2013-04-16 Durect Corporation Oral drug delivery system

Similar Documents

Publication Publication Date Title
US6054122A (en) Supplemented and unsupplemented tissue sealants, methods of their production and use
US5968542A (en) High viscosity liquid controlled delivery system as a device
US7196054B1 (en) Methods for treating wound tissue and forming a supplemented fibrin matrix
US6117425A (en) Supplemented and unsupplemented tissue sealants, method of their production and use
US6197325B1 (en) Supplemented and unsupplemented tissue sealants, methods of their production and use
CA2343223C (en) Anti-inflammatory and antimicrobial uses for bioactive glass compositions
Cao et al. Porous gelatin microspheres for controlled drug delivery with high hemostatic efficacy
EP0560014A1 (en) Biodegradable film dressing and method for its formation
JP6862441B2 (ja) セルロース系短尺繊維及び長尺繊維の止血混合物
WO1996040174A1 (en) Supplemented and unsupplemented tissue sealants, methods of their production and use
KR101883807B1 (ko) 뼈 보이드 및 개방형 골절의 치료용 조성물 및 방법
US5472702A (en) Sterilization of growth factors
AU2015321554C1 (en) Porous foams derived from extracellular matrix, porous foam ECM medical devices, and methods of use and making thereof
WO2007070561A2 (en) Agents for controlling biological fluids and methods of use thereof
CN109689069A (zh) 具有止血作用的伤口覆盖物及其产生方法
US20100143490A1 (en) Composite material
JP3740449B2 (ja) 連続した微細空洞を有する物体の抗生物質による被覆のための方法、こうして被覆された物体及びその使用
EP0494369A2 (en) Sterilization of growth factors
KR20110055535A (ko) 지혈제로서 콜레스테릴 설페이트를 포함하는 조성물
RU2322266C2 (ru) Альгинатные пенообразные композиции
RU2774582C1 (ru) Гемостатический раствор с противолимфорейными свойствами и способ его приготовления
KR100393409B1 (ko) 골수염 치료용 항생제 함유 해면 골편의 제조 방법 및 그방법에 따라 제조된 해면 골편
AU5053200A (en) Supplemented and unsupplemented tissue sealants, methods of their production and use
HK1204545B (en) Compositions and methods for the treatment of bone voids and open fractures